[ad_1]
American pharmacist Eli Lilly has suspended clinical trials for the Covid-19 treatment that has been developed so far, after doubts were raised about the possibility of “Possible security problems”.
That was the expression that, according to The New York Times, US government officials used in correspondence with investigators. However, this is a relatively common decision in vaccine and treatment development, and it comes a month after Astrazeneca and a day after Johnson & Johnson did the same when questions were raised about the vaccines they are developing.
This decision comes after Donald Trump spoke on October 7 about Eli Lilly, as well as Regeneron, the company that produces the cocktail antiviral drug that the president of the United States took when he was hospitalized with Covid-19.
“We have Regeneron, we have a drug very similar to Eli Lilly, which will be available. We are trying to make them available through an emergency measure. I authorized them, “said Donald Trump, in a message recorded at the White House, shortly after being discharged.
A MESSAGE FROM THE PRESIDENT! pic.twitter.com/uhLIcknAjT
– Donald J. Trump (@realDonaldTrump) October 7, 2020
Although he said this time that he authorized them, in reality Donald Trump did not. – although The Washington Post found there was pressure from the president and the White House to ensure that the Food and Drug Administration, the regulator, would allow the generalization of those two treatments.
Donald Trump has referred to both as a “cure.” “They call it therapies, but for me it was not therapy, it just made me better,” he said. “For me this is a cure,” he added, saying that for now this approach is “more important than a vaccine.”
The pause in clinical trials, known as ACTIV-3, was taken by Eli Lilly herself, and a spokeswoman for the pharmacist said this decision, made by an independent team, was made with a spirit of caution.
“As a matter of immense caution, ACTIV3’s independent data monitoring team recommended a break from work.”said spokeswoman Molly McCully. “Lilly supports this decision by the independent data monitoring team to carefully ensure the safety of all patients participating in this study.”
The specific reason that led to the suspension of the Eli Lilly tests is still unknown, that is, if it was due to the possibility that any of the patients tested had an adverse reaction, as also happened with the Astrazeneca vaccines and Johnson and Johnson.
[ad_2]
